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fragment that lacks the binding domain for alpha-dystroglycan
Abstract
Agrin induces both phosphorylation and aggregation of nicotinic acetylcholine receptors (AChRs) when
added to myotubes in culture, apparently by binding to a specific receptor on the myotube surface. One
such agrin receptor is alpha-dystroglycan, although binding to alpha-dystroglycan appears not to
mediate AChR aggregation. To determine whether agrin-induced AChR phosphorylation is mediated by
alpha-dystroglycan or by a different agrin receptor, fragments of recombinant agrin that differ in affinity
for alpha-dystroglycan were examined for their ability to induce AChR phosphorylation and aggregation
in mouse C2 myotubes. The carboxy-terminal 95 kDa agrin fragment agrin-c95(A0B0), which binds to
alpha-dystroglycan with high affinity, failed to induce AChR phosphorylation and aggregation. In
contrast, agrin-c95(A4B8) which binds less strongly to alpha-dystroglycan, induced both
phosphorylation and aggregation, as did a small 21 kDa fragment of agrin, agrin-c21(B8), that
completely lacks the binding domain for alpha-dystroglycan. We conclude that agrin-induced AChR
phosphorylation and aggregation are triggered by an agrin receptor that is distinct from
alpha-dystroglycan.
The EMBO Journal vol.15 no.11 pp.2625-2631, 1996
AChR phosphorylation and aggregation induced by
an agrin fragment that lacks the binding domain for
a-dystroglycan
Thomas Meier, Matthias Gesemann1,
Valeria Cavalli1, Markus A.Ruegg1 and
Bruce G.Wallace2
Department of Physiology, University of Colorado Health Sciences
Center, Denver, CO 80262, USA and 'Department of Pharmacology,
Biozentrum, University of Basel, Basel, Switzerland
2Corresponding author
Agrin induces both phosphorylation and aggregation
of nicotinic acetylcholine receptors (AChRs) when
added to myotubes in culture, apparently by binding
to a specific receptor on the myotube surface. One
such agrin receptor is a-dystroglycan, although binding
to a-dystroglycan appears not to mediate AChR
aggregation. To determine whether agrin-induced
AChR phosphorylation is mediated by a-dystroglycan
or by a different agrin receptor, fragments of recombin-
ant agrin that differ in affinity for a-dystroglycan were
examined for their ability to induce AChR phosphoryl-
ation and aggregation in mouse C2 myotubes. The
carboxy-terminal 95 kDa agrin fragment agrin-c95AQB0,
which binds to a-dystroglycan with high affinity, failed
to induce AChR phosphorylation and aggregation. In
contrast, agrin-c95A4B8, which binds less strongly to
a-dystroglycan, induced both phosphorylation and
aggregation, as did a small 21 kDa fragment of agrin,
agrin-c21B8, that completely lacks the binding domain
for a-dystroglycan. We conclude that agrin-induced
AChR phosphorylation and aggregation are triggered
by an agrin receptor that is distinct from a-dystro-
glycan.
Keywords: acetylcholine receptor/agrin/dystroglycan/neuro-
muscular junction/protein tyrosine phosphorylation.
Introduction
An important step in the formation of the vertebrate
skeletal neuromuscular junction is the nerve-induced accu-
mulation of nicotinic acetylcholine receptors (AChRs),
acetylcholinesterase (AChE) and other components, in the
post-synaptic apparatus. Agrin, a protein originally isolated
from Torpedo electric organ, appears to play a crucial role
in this process (McMahan and Wallace, 1989; McMahan,
1990; Hall and Sanes, 1993). Agrin is synthesized by
motor neurons, is transported anterogradely along their
axons and is deposited in the synaptic basal lamina. When
added to myotubes in culture, agrin induces the formation
of specializations at which many components of the post-
synaptic apparatus accumulate, including AChRs and
AChE. Both nerve- and agrin-induced AChR aggregation
are blocked by anti-agrin antibodies (Reist et al., 1992).
These and other findings suggest that agrin is the neural
signal that triggers the formation of post-synaptic specializ-
ations at developing neuromuscular junctions.
Agrin is a 400-600 kDa heparan sulfate proteoglycan
with a multi-domain structure (Denzer et al., 1995; Tsen
et al., 1995). Agrin's AChR-aggregating activity is local-
ized to the 95 kDa carboxy-terminal portion of the protein,
which contains three domains homologous to the globular
(G) domains of the laminin X chain (Nitkin et al., 1987;
Sasaki et al., 1988; Tsim et al., 1992; Ferns et al., 1993;
Gesemann et al., 1995). Various isoforms of agrin result
as a consequence of alternative splicing within this region.
Inserts at two sites near the carboxy-terminal end, desig-
nated as A and B in chick and ray and y and z in rat,
appear to regulate the ability of agrin to induce AChR
aggregation (Rupp et al., 1991, 1992; Ferns and Hall,
1992; Ferns et al., 1992, 1993; McMahan et al., 1992;
Ruegg et al., 1992; Smith et al., 1992). Each of the splice
sites lies within or adjacent to a G-domain. For the A site,
the presence or absence of a four amino acid insert results
in A4 and AO variants, whereas for the B site there are
0, 8 and/or 11 amino acids inserted leading to BO, B8,
B 11 and B 19 isoforms (see Figure 1). In chick and rat,
agrin isoforms that contain amino acid inserts at the B
site always have the four amino acid insert at the A
site. Recombinant carboxy-terminal fragments of agrin
isoforms with inserts at both splice sites, such as A4B8,
A4B 11 and A4B 19 are capable of inducing AChR aggrega-
tion on cultured muscle cells. Motor neurons express high
levels of such isoforms (Tsim et al., 1992; Hoch et al.,
1993; Ma et al., 1994, 1995; Smith and O'Dowd, 1994).
Muscle cells, on the other hand, synthesize agrin isoforms
that lack inserts at one or both sites [AOBO, A4BO (Ruegg
et al., 1992; Hoch et al., 1993; Ma et al., 1994)]; such
isoforms are only weakly active or inactive in AChR
aggregation assays when added in a soluble form to
cultured myotubes (Ruegg et al., 1992; Gesemann et al.,
1995).
Previous work suggested that agrin- and nerve-induced
AChR aggregation is mediated by an increase in protein
tyrosine phosphorylation (Wallace et al., 1991; Qu and
Huganir, 1994; Meier et al., 1995). Thus, treatment of
cultured myotubes with agrin leads to the formation
of domains within myotubes that stain intensely with
antibodies to phosphotyrosine (Wallace et al., 1991; Meier
et al., 1995). Agrin-induced AChR aggregates co-localize
with such phosphotyrosine-enriched domains. Protein
kinase antagonists that inhibit agrin-induced tyrosine phos-
phorylation also block agrin-induced AChR aggregation
(Wallace, 1994). One component of the myotube mem-
brane that becomes phosphorylated on tyrosine residues
in agrin-treated myotubes is the AChR itself, most con-
spicuously the AChR 0 subunit (Wallace et al., 1991; Qu
and Huganir, 1994; Meier et al., 1995). These and other
findings suggest that binding of agrin to a receptor on
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Fig. 1. Structural domains of chick agrin fragments. Simplified
representation of the carboxy-terminal part of full-length chick agrin.
Alternative splicing occurs at site A (O or 4 amino acid insert) and site
B (0, 8 and/or 11 amino acid insert). Shaded boxes represent
epidermal growth factor (EGF)-like domains. The crosshatched box
indicates a Ser/Thr-rich domain. Laminin a-like G-domains are
indicated as G1, G2 and G3. In this study, recombinant fragments
corresponding to the 95 kDa C-terminal portion of agrin (c95), the
second laminin a-like domain (G2) and the third laminin a-like
domain (c21) were used (for more details, see Gesemann et al., 1995).
the myotube surface activates a protein tyrosine kinase,
resulting in a localized increase in protein tyrosine
phosphorylation of AChRs and perhaps other proteins as
well. If one consequence of this increase in tyrosine
phosphorylation were that AChRs became attached to the
cytoskeleton, then AChRs would accumulate near the
site of the activated kinase, thereby creating a receptor
aggregate (Meier et al., 1995; Wallace, 1995).
A crucial step in testing such a hypothesis is the
identification of the agrin receptor. Motivated by the
observation that binding of laminin to a-dystroglycan is
mediated by G-domains for which homologs exist in
agrin, several laboratories have shown that agrin binds to
a-dystroglycan, a component of the dystrophin-associated
glycoprotein complex (for reviews, see Matsumura and
Campbell, 1994; Tinsley et al., 1994). This observation led
to the hypothesis that binding of agrin to a-dystroglycan
triggers the formation of AChR aggregates (Bowe et al.,
1994; Campanelli et al., 1994; Gee et al., 1994; Sugiyama
et al., 1994). However some experimental results appear
inconsistent with this hypothesis: (i) Agrin isoforms that
are inactive in AChR aggregation assays bind to
a-dystroglycan with an affinity that is similar to or higher
than that of isoforms with AChR-aggregating activity
(Sugiyama et al., 1994; Gesemann et al., 1996). (ii) Excess
amounts of the inactive agrin isoform c95AoBo do not
block agrin-induced AChR aggregation, but cause only a
slight shift in the dose-response curve (Gesemann et al.,
1996). (iii) Experiments using mAb 11H6, which blocks
binding of agrin to a-dystroglycan, give conflicting results.
While Gee et al. (1994) reported that mAb IIH6 inhibited
agrin-induced AChR aggregation, Sugiyama et al. (1994)
and Cohen et al. (1995) saw little or no effect on agrin-
or nerve-induced receptor aggregation. Campanelli et al.
(1994) found that mAb IIH6 influenced the size but not
the number of agrin-induced receptor patches. (iv) Recent
studies using recombinant agrin show that a 21 kDa
fragment, comprising the B splice site with the eight
amino acid insert and the most carboxy-terminal G-domain
(c2l B8, see Figure 1), does not bind to a-dystroglycan but
is sufficient to induce AChR aggregation on cultured
myotubes (Gesemann et al.. 1995, 1996). This led to the
conclusion that binding to ax-dystroglycan is not required
for agrin-induced AChR aggregation (Gesemann et al.,
1995, 1996). Here we report that in mouse C2 myotubes
the ability of different agrin fragments and isoforms to
induce AChR phosphorylation varied in parallel with their
ability to induce AChR aggregation rather than with their
ability to bind to a-dystroglycan. Isoforms that lack inserts
at the A and B splice sites and bind with high affinity to
a-dystroglycan caused neither AChR phosphorylation nor
aggregation, while the small c21B8 fragment, which does
not bind to a-dystroglycan, induced both AChR phos-
phorylation and aggregation. These findings support the
hypothesis that the functional agrin receptor triggers both
phosphorylation and aggregation and is distinct from
a-dystroglycan.
Results
Agrin induces aggregation ofAChRs on vertebrate skeletal
myotubes and causes phosphorylation of the AChR ,
subunit. Agrin also binds to a-dystroglycan, although such
binding does not appear to mediate AChR aggregation
(Gesemann et al., 1996). As a step towards identifying
the agrin receptor mediating AChR phosphorylation, we
have compared directly and quantitatively the ability
of agrin fragments that differ in their affinity for a-
dystroglycan to induce AChR aggregation and phospho-
rylation.
Binding to ac-dystroglycan is not sufficient for
induction of AChR phosphorylation
To study changes in the phosphorylation of AChR f8
subunits, cultured C2 myotubes were incubated overnight
with medium containing [32P]orthophosphate and treated
for 4 h with various isoforms of agrin. AChRs were
purified, the subunits separated by SDS-PAGE and the
incorporation of radioactive phosphate measured by auto-
radiography. As illustrated in Figure 2, 85 pM of the
recombinant agrin isoform c95A4B8, which is known to
induce receptor aggregation, increased phosphorylation of
the AChR 1 subunit to the same extent as was observed
with saturating amounts of Torpedo agrin (Meier et al.,
1995). In contrast, 85 pM c95AOBo, an agrin isoform that
is inactive in AChR aggregation assays but, like c95A4B8,
binds to ax-dystroglycan (Sugiyama et al., 1994; Gesemann
et al., 1996), did not increase AChR P subunit phosphoryla-
tion over control levels. Likewise, laminin- 1, another
ligand for a-dystroglycan (Gee et al., 1994; Yamada et al.,
1994; Gesemann et al., 1996) did not induce ,B subunit
phosphorylation, at concentrations as high as 200 nM
(data not shown). Thus, binding of agrin or laminin-1 to
a-dystroglycan is not sufficient for the induction of
phosphorylation of the AChR 1 subunit.
As demonstrated previously, Torpedo agrin not only
induces AChR ,B subunit phosphorylation but also causes
phosphorylation of AChR y and 6 subunits (Meier et al.,
1995). A comparable increase in AChR y and 6 subunit
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Fig. 2. Agrin isoformns differ in their ability to induce AChR
phosphorylation. (a) C2 myotube cultures were labeled overnight with
[32P]orthophosphate, treated for 4 h with agnin and the AChRs isolated
and analyzed by SDS-PAGE and autoradiography. AChR 3, y and 6
subunits were identified according to their Mr as described (Meier
et al., 1995). Compared with control cultures (con), addition of 4 U of
Torpedo agrin (CE) and 85 pM c9SA4es (A4B8) induced
phosphorylation of the AChR ,B subunit. No such increased level of
phosphorylation was induced with 85 pM c9SAoBo (AOBO).
(b) Quantitative analysis of agrin-induced changes in AChR p3 subunit
phosphorylation. The level of incorporation of [32P]orthophosphate
into AChR ,B subunits was measured by densitometric analysis of
autoradiograms. Data from different experiments were combined by
normalizing the results of each experiment to the subunit of control
myotubes in normal medium (= 1000; see Meier et a!., 1995).
Compared with controls (con), Torpedo agrin (CE) and recombinant
c9SA4Bs agrin, but not c9SAOBO, significantly increased phosphorylation
of the AChR subunit. Data are mean SEM, N =14-18. *Differs
significantly from control cultures, P<0.05 (one-way ANOVA, Tukey-
Kramer HSD test).
phosphorylation was observed with c9SA4B8, but not with
c9SAoBo (data not shown). Phosphorylation of AChR y
and 6 subunits occurs predominantly on serine residues,
with little change in phosphotyrosine content (Meier et al.,
1995). Agrin-induced protein serine phosphorylation of
the y and 6 subunits is not required for AChR aggregation
(Wallace et al., 1991); therefore, we restricted our analyses
to changes of AChR ,B subunit phosphorylation.
AChR-aggregating activity of agrin isoforms
parallels their potency for inducing
phosphorylation
As a step towards determining if both AChR aggregation
and phosphorylation are triggered by the same agrin
receptor, we measured the extent of AChR aggregation
and phosphorylation as a function of concentration for the
c9SA4Bg, c9SA4Bll and c9SAoBo agrin isoforms. Previous
receptor aggregation assays on chick myotubes had demon-
strated that c9SA4B8 was the most active isoform, c9SA4BII
was --140-fold less active and c9SAoBo was completely
Fig. 3. The relative potency of agrin isoforms is similar in AChR
aggregation and phosphorylation assays. (A) Dose-response curve for
AChR aggregation. Activity is expressed as the percentage of the cell
surface area occupied by AChR clusters following an overnight
incubation with the indicated c95 agrin isoform. Each data point
represents the mean ± SEM of 20 myotube segments analysed. The
half-maximal response for c95A4B8 (A4B8) was -100 pM and for
c95A4BII (A4B1 1) was -4 nM. No AChR-aggregating activity was
observed for c95AOBO (AOBO) at concentrations up to 200 nM. The
dotted line represents the percentage area occupied by AChR
aggregates in control cultures [mean: 0.38 ± 0.11 (SEM); N = 20].
(B) Dose-response curve for AChR subunit phosphorylation. The
level of ,B subunit phosphorylation was determined by densitometric
analysis after separation of 32P-labeled AChR subunits from cultures
incubated with agrin isoforms for 4 h. Half-maximal responses were
reached at -4 pM for c95A4B8 and -50 pM for c95A4BI1. Each data
point represents the mean SEM with N = 3-10 for c95A4B8,
N = 3-6 for c95A4BIl and N = 7 and 18 for c95AoBO. The dotted line
represents the level of subunit phosphorylation in control cultures
[mean: 152.0 ± 5.4 (SEM); N = 47].
inactive (Gesemann et al., 1995). These isoforms had the
same relative potency on mouse C2 cells (Figure 3A).
The concentration of c95A4B8 that induced half-maximal
receptor aggregation was -100 pM, while c95A4BlI had a
half-maximal response at -4 nM and c95AOBO failed to
induce aggregation at concentrations as high as 200 nM.
When assayed for their ability to induce phosphorylation
of the AChR subunit (Figure 3B), these isoforms again
had the same order of potency; c95A4B8 reached a half-
maximal response at -4 pM, c95A4B 1 at -50 pM and
c95AoBO had no effect at concentrations as high as 200 nM.
The finding that the ability of different agrin isoforms to
induce AChR phosphorylation varied in parallel with
their AChR-aggregating activity is consistent with the
hypothesis that the same agrin receptor mediates both
effects.
A 21 kDa agrin fragment that lacks the binding
domain for a-dystroglycan is sufficient to induce
AChR aggregation and phosphorylation
As previously shown, a short -21 kDa agrin fragment,
comprising the third G-domain (G3) and the B splice site
(c2lB8, see Figure 1), induces AChR aggregation on chick
myotubes (Gesemann et al., 1995). To determine whether
the third G-domain is sufficient to induce AChR phos-
phorylation and whether this effect is splice site dependent,
we compared the ability of c21Bo and c21B8 agrin fragments
to induce AChR aggregation and subunit phosphoryl-
ation. Additionally, since agrin-induced AChR aggregation
is inhibited by heparin (Wallace, 1990) and the second
G-domain (G2) contains the heparin binding site
(Gesemann et al., 1996), we also tested individual second
G-domain (G2) agrin fragments, with or without amino
acid inserts (G2AO and G2A4), for their effect on AChR
aggregation and phosphorylation.
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Fig. 4. AChR aggregation and phosphorylation by individual agrin
G-domains. (a) AChR aggregates induced by agrin fragments.
Fluorescence micrographs of segments of cultured C2 myotubes
labeled with rhodamine-ax-bungarotoxin. Overnight incubation with
20 nM c95A4B8 (A4B8), 20 nM c2IB8 (B8) or 200 nM c2lIBO (BO).
Bar: 40 gm. (b) Quantitative analysis of AChR-aggregating activity.
For each fragment, the percentage of myotube surface area occupied
by AChR aggregates was determined after overnight incubation with
400 nM G2AO (AO), G2A4 (A4), c21 BO (BO) or c2IB8 (B8) and
compared with effects induced by 2 nM c95A4B8 (A4B8) and with
control cultures (con). Of the 21 kDa fragments, only c21B8 caused a
significant increase in AChR aggregation. (c) AChR P subunit
phosphorylation induced by agrin fragments. Autoradiography of
32P-labeled AChR subunits isolated after a 4 h incubation with
200 nM of the short agrin fragments (G2AO, G2A4, c2 IBO, c2lB8) or
200 pM c95A4B8. (d) Quantitative analysis of AChR subunit
phosphorylation. C2 myotubes were incubated for 4 h with 200 nM of
each of the short agrin fragments and the extent of phosphorylation of
the subunit compared with that obtained with 200 pM c95A4B8 and
controls. The only 21 kDa fragment that significantly increased
subunit phosphorylation was c2IB8. There is no significant
difference in the extent of subunit phosphorylation induced by c2 1B8
and c95A4B8 (mean ± SEM; N = 6-12). *Differs significantly from
control cultures, P<0.05 (one-way ANOVA, Tukey-Kramer HSD
test).
As shown in Figure 4, the second G-domain was
inactive in AChR aggregation and phosphorylation assays,
regardless of the presence or absence of amino acid inserts
at the A splice site. In contrast, the fragment containing
the third G-domain induced both aggregation and phos-
phorylation, provided it contained an insert at the B
splice site (c2lB8). The c2lBM fragment does not bind to
ca-dystroglycan (Gesemann et al., 1996). Thus, an agrin
fragment that does not bind to a-dystroglycan induces
both AChR phosphorylation and aggregation.
Next we compared the dose-response relationship for
the formation of AChR aggregates and induction of c
subunit phosphorylation for c2lB8 (Figure 5). Half-
maximal receptor aggregation was reached at -4 nM,
whereas half-maximal 0 subunit phosphorylation occurred
at ~300 pM. Thus, as was the case for c95 constructs,
half-maximal phosphorylation occurred at a lower concen-
tration of agrin than half-maximal receptor aggregation
(see Discussion).
The c21B8 agrin fragment induces tyrosine
phosphorylation of the AChR subunit
Results of previous experiments indicate that agrin causes
conspicuous changes in the phosphotyrosine content of
-1 1 -10 -9 -8 -7 -6
concentration (log M)
Fig. 5. Dose dependence of c2 1 B8-induced AChR aggregation and
P subunit phosphorylation. Open symbols: AChR aggregation. Each
data point represents the mean ± SEM of 20 myotube segments. The
half-maximal response was reached at -4 nM. Closed symbols: AChR
f subunit phosphorylation. Data, expressed as the mean + SEM
(N = 5-7), represent the level of f subunit phosphorylation induced
by c2lB8 as determined by densitometric analysis. The half-maximal
response was reached at -300 pM.
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Fig. 6. The c2 B8 agrin fragment induces tyrosine phosphorylation of
the AChR P subunit. Myotubes were labeled with [32P]inorganic
phosphate, treated with agrin isoforms, AChRs isolated and the
phosphotyrosine content of the P subunit estimated. The results of
each experiment were normalized to the phosphotyrosine content of
f subunits from control cultures (= 100%). Data are expressed as the
mean + SEM; N = 7 for control (con) and c95A4B8 (A4B8), N = 6
for c2lB8 (B8). *Differs significantly from control, P<0.05 (one-way
ANOVA, Tukey-Kramer HSD test).
AChR , subunits (Wallace et al., 1991; Qu and Huganir,
1994; Meier et al., 1995) and that protein tyrosine phos-
phorylation is required for agrin-induced AChR aggrega-
tion (Wallace, 1994, 1995). To determine whether C2lB8
induces tyrosine phosphorylation of the AChR 0 subunit,
mouse C2 myotubes were incubated in medium containing
[32P]inorganic phosphate and were treated with either
c2lB8 or c95A4B8. AChRs were isolated, the subunits
separated by SDS-PAGE and the phosphotyrosine content
of the f8 subunit examined by selective hydrolysis of
phosphoserine residues with 1 M KOH (see Materials and
methods; Cooper and Hunter, 1981). As illustrated in
Figure 6, c2lB8 as well as c95A4B8 agrin isoforms induced
tyrosine phosphorylation of the AChR , subunit. Thus,
as previously shown for Torpedo agrin, recombinant chick
2628
Agrin-induced AChR phosphorylation and aggregation
agrin fragments, including c21B8, trigger tyrosine phos-
phorylation of the AChR ,B subunit.
Discussion
The results reported here demonstrate that, when added to
C2 myotubes in culture, the c21B8 fragment of recombinant
agrin, which does not bind to a-dystroglycan, causes
AChR aggregation and tyrosine phosphorylation of the
AChR c subunit. On the other hand, the c95AoBo fragment
of recombinant agrin, which binds with high affinity to
a-dystroglycan, does not induce either AChR aggregation
or phosphorylation. We conclude that agrin-induced AChR
phosphorylation and aggregation are triggered by a muscle
surface agrin receptor that is distinct from ax-dystroglycan.
Role of a-dystroglycan in mediating the effects of
agrin
The changes in AChR distribution and phosphorylation
induced by the agrin fragment c21B8, which does not bind
to a-dystroglycan, are qualitatively indistinguishable from
those induced by longer agrin fragments, such as c95A4B8,
that do bind to ax-dystrogylcan. This indicates that binding
of agrin to ax-dystroglycan is not required for AChR
phosphorylation or aggregation. However, a-dystroglycan
does accumulate at agrin- and nerve-induced specializ-
ations and may well play a role in their formation and/or
stabilization (Phillips et al., 1993; Campanelli et al., 1994;
Cohen et al., 1995). For example, Sugiyama et al. (1994)
suggested that binding of agrin to a-dystroglycan might
act to increase the effective concentration of agrin in the
vicinity of developing aggregates, thereby facilitating its
interaction with the agrin receptor that mediates AChR
phosphorylation and aggregation. Indeed, Gesemann et al.
(1996) provide evidence that binding to a-dystroglycan
reduces the concentration of agrin required for a half-
maximal response by a factor of 2. Alternatively,
a-dystroglycan, as well as other components of the dystro-
phin-utrophin complex, might be required for the inter-
action of AChRs with the cytoskeleton that is thought to
mediate the immobilization of AChRs at sites of aggregate
formation (Froehner, 1993; Apel and Merlie, 1995; Apel
et al., 1995; Cohen et al., 1995). Thus, agrin-induced
increases in protein tyrosine phosphorylation might alter
the interactions between AChRs, the 43 kDa receptor-
associated protein (rapsyn; Froehner, 1993) and proteins
of the dystrophin-utrophin complex such that all of these
components become tethered together to the underlying
cytoskeleton. In fact, recent experiments using mutant
mice with a targeted disruption of the Rapsn gene directly
demonstrated the importance of rapsyn for the formation
of AChR aggregates (Gautam et al., 1995).
On the other hand, interaction of agrin with a-dystrogly-
can might play a role unrelated to AChR aggregation,
both at synaptic sites and elsewhere. In muscle for example,
myofibers synthesize agrin isoforms, lacking inserts at one
or both A and B splice sites, that bind to a-dystroglycan but
do not induce AChR aggregation. a-Dystroglycan, in turn,
is found in extrasynaptic regions of muscle fibers (Cohen
et al., 1995). Whether or not agrin interacts with
a-dystroglycan at such sites and, if so, what the functional
consequences of such an interaction might be, remain to
be determined.
Agrin-induced AChR aggregation and
phosphorylation
Recombinant agrin fragments that induced AChR aggrega-
tion also caused AChR phosphorylation, while fragments
that did not induce aggregation did not cause receptor
phosphorylation. In particular, we found that the small
recombinant chick agrin fragment c21B8 induced both
tyrosine phosphorylation of the AChR P subunit and AChR
aggregation. Thus, based on the constructs described in
this report, the domains within agrin that mediate AChR
aggregation could not be separated from those that cause
phosphorylation; the third G-domain containing an insert
at the B splice site is both necessary and sufficient to
induce AChR phosphorylation and aggregation. These
findings provide support for the hypothesis that the same
agrin receptor triggers both AChR phosphorylation and
aggregation.
Dose dependence of agrin-induced AChR
aggregation and phosphorylation
In previous experiments on chick myotubes, AChR
aggregation and tyrosine phosphorylation were found to
depend in the same manner on agrin concentration
(Wallace, 1992), as would be expected if the combination
of agrin with a receptor on the myotube surface triggered
an increase in tyrosine phosphorylation that caused AChR
aggregation. In the current study on C2 myotubes, how-
ever, agrin-induced AChR phosphorylation reached half-
maximal levels at a concentration of agrin that was at
least 10-fold lower than that necessary to induce half-
maximal AChR aggregation. The apparent discrepancy
may result from the manner in which AChR aggregation
was measured. In the present study, the extent of receptor
aggregation was determined by estimating the fraction of
the C2 cell surface covered by receptor aggregates. For
this analysis, small aggregates (<4 gm in their longest
axis) were ignored, and the density of receptors within
aggregates was not taken into account. Thus, relatively
small, low density aggregates, such as might be produced
by low concentrations of agrin, would not contribute to
the measured extent of aggregation, artifactually shifting
the dose-response curve for aggregation to higher agrin
concentrations.
Of course, other explanations cannot be ruled out. If
aggregation were a cooperative process, requiring the
interaction of several phosphorylated receptors for
example, this would also tend to create a difference in the
dose-response curves for aggregation and phosphoryl-
ation. Another possibility might be that proteins other
than AChRs must become phosphorylated to a certain
level before aggregation can occur.
Regardless of the relationship between AChR phos-
phorylation and aggregate formation, the results reported
here demonstrate that both agrin-induced AChR phos-
phorylation and aggregation are mediated by a receptor
that is distinct from a-dystroglycan.
Materials and methods
Agrin constructs and expression
The recombinant chick agnrin fragments used in this study were described
by Gesemann et al. (1996). Fragments comprising the second G-domain
with or without the four amino acid insert at the A splice site are
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designated as G2A4 and G2AO respectively, whereas fragments composed
of the third G-domain and the associated B splice site are designated
c2IBo and c21B8 (Gesemann et al., 1995, 1996). Partially purified agrin
from Torpedo electric organ (Cibacron pool) was prepared as described
earlier (Nitkin et al., 1987) and used at a saturating dose (4 U).
Cell cultures and aggregation assays
C2C12 cells (Yaffe and Saxel, 1977; Blau et al., 1983) were grown in
35 mm tissue culture dishes in proliferation medium until they reached
confluence. Cells subsequently were changed to differentiation medium
as described earlier (Gesemann et al., 1995; Meier et al., 1995). After
4-6 days, cells had fused and were used for AChR aggregation and
phosphorylation assays. For aggregation assays, cultures were incubated
with agrin isoforms for 16 h. AChRs were labeled with 4x 10-8 M
rhodamine-a-bungarotoxin (Molecular Probes, Eugene, OR) and AChR
aggregation was determined by estimating the fraction of the C2 cell
surface covered by receptor aggregates. Only AChR aggregates with a
longer axis of at least 4 jim were included in the counting (see Gesemann
et al., 1995 for details).
Measurement of AChR phosphorylation
AChR phosphorylation was assayed as previously described (Meier
et al., 1995) with minor modifications. Briefly, C2 cultures were rinsed
with MEM without sodium phosphate (GIBCO BRL) supplemented with
1 mg/ml bovine serum albumin (RIA grade, Sigma Chemical Co.),
20 ,ug/mI conalbumin (type II, Sigma Chemical Co.), 100 U/ml penicillin
and 100 ,ug/ml streptomycin, followed by a 16 h incubation in the same
medium containing 0.25 mCi/ml [32P]orthophosphate ([32P]H3PO4 in
H20, ICN Biomedicals Inc., Costa Mesa, CA). Agrin isoforms were
added to this culture medium at the designated concentrations during
the last 4 h of incubation. AChRs were labeled with biotinylated
ax-bungarotoxin (Wallace et al., 1991; Meier et al., 1995) and toxin-
AChR complexes were solubilized by incubation for 10 min on ice in
extraction buffer [20 mM sodium phosphate buffer, pH 7.4, supplemented
with 5 mM EDTA, 5 mM EGTA, 50 mM sodium fluoride, 40 mM
sodium pyrophosphate, 10 mM sodium molybdate, I mM sodium
orthovanadate, 5 jg/mI aprotinin, 5 gg/ml leupeptin, 1 mM phenylmethyl-
sulfonyl fluoride (PMSF), 1% (w/v) Triton X-100 and 0.25% (w/v)
deoxycholate]. Extracts were cleared and toxin-AChR complexes purified
on streptavidin-conjugated agarose beads. Bead complexes were washed
thoroughly and eluted into SDS sample buffer at room temperature.
AChR subunits were separated by SDS-PAGE on 7.5% gels. Gels were
fixed, dried and exposed to pre-flashed autoradiography film (Hyperfilm-
MP, Amersham, Arlington Heights, IL) and autoradiograms analyzed by
densitometry as previously described (Wallace, 1994). AChR j, and 6
subunits were identified by their position relative to pre-stained molecular
weight markers and by criteria described previously (Meier et al., 1995).
For all densitometric analyses, data from different experiments were
combined by normalizing the results of each experiment to the 6 subunit
of control myotubes in normal medium (= 1000).
Assay for tyrosine phosphorylation
To estimate the level of tyrosine phosphorylation of AChR i subunits,
isolated subunits were treated with base. Briefly, 32P-labeled AChR j3
subunits were identified on SDS-polyacrylamide gels, gel pieces cut out
and total 32p incorporation determined by measuring Cerenkov radiation.
Gel slices were treated with I M KOH at 60°C for 90 min to hydrolyze[32p]PO4 from serine residues, washed and counted again. Alkali
hydrolysis reduced the amount of radioactive phosphate in AChR f
subunits isolated from control cultures by 76% (SEM: ± 2.8; N = 7),
for c95A4B8-treated subunits by 55% (SEM: + 3.0; N = 7) and for
c2IB8-treated subunits by 52% (SEM: ± 8.8; N = 6). The AChR J3
subunit contains phosphotyrosine and phosphoserine, but no detectable
phosphothreonine (Qu and Huganir, 1994; Meier et al., 1995). Since
base treatment hydrolyzes >90% of phosphoserine residues while -40%
of phosphotyrosine residues attached to proteins are recovered, we
conclude that the radioactivity still associated with base-treated ,Bsubunits
is due predominantly to phosphotyrosine (Cooper and Hunter, 1981).
Similar results were obtained using anti-phosphotyrosine antibodies on
Western blots (data not shown).
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